Leaders
Lisata Therapeutics adds Jeffrey Farrow to board, expanding it to eight
The Tarsus Pharmaceuticals finance chief will also sit on Lisata's audit committee as the company runs two Phase 2b programs.
Leaders
The Tarsus Pharmaceuticals finance chief will also sit on Lisata's audit committee as the company runs two Phase 2b programs.